Avanos Medical, Inc.
AVNS
Price:
$16.03
Market Cap:
$736.69M
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps...[Read more]
Industry
Medical - Devices
IPO Date
2014-10-21
Stock Exchange
NYSE
Ticker
AVNS
PE Ratio
[34.11]
ROE
[1.28%]
Current Ratio
[2.22]
Dividend Yield
[0%]
Enterprise Value
[849.89M]
Dividend History
The ROE as of December 2024 (TTM) for Avanos Medical, Inc. (AVNS) is 1.28%
According to Avanos Medical, Inc.’s latest financial reports and current stock price. The company's current ROE is 1.28%. This represents a change of 301.41% compared to the average of 0.32% of the last 4 quarters.
Avanos Medical, Inc. (AVNS) Historical ROE (quarterly & annually)
How has AVNS ROE performed in the past?
The mean historical ROE of Avanos Medical, Inc. over the last ten years is -3.04%. The current 1.28% ROE has changed -142.03% with respect to the historical average. Over the past ten years (40 quarters), AVNS's ROE was at its highest in in the June 2021 quarter at 2.92%. The ROE was at its lowest in in the September 2015 quarter at -45.20%.
Average
-3.04%
Median
1.16%
Minimum
-40.40%
Maximum
6.52%
Avanos Medical, Inc. (AVNS) ROE by Quarter and Year
Discovering the peaks and valleys of Avanos Medical, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 684.64%
Maximum Annual ROE = 6.52%
Minimum Annual Increase = -2322.83%
Minimum Annual ROE = -40.40%
| Year | ROE | Change |
|---|---|---|
| 2023 | -5.00% | -227.81% |
| 2022 | 3.91% | 684.64% |
| 2021 | 0.50% | -123.03% |
| 2020 | -2.16% | -40.33% |
| 2019 | -3.63% | -181.85% |
| 2018 | 4.43% | -32.06% |
| 2017 | 6.52% | 80.74% |
| 2016 | 3.61% | -108.94% |
| 2015 | -40.40% | -2322.83% |
| 2014 | 1.82% | -75.56% |
Avanos Medical, Inc. (AVNS) Average ROE
How has AVNS ROE performed in the past?
The current ROE of Avanos Medical, Inc. (AVNS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.20%
5-year avg
-1.28%
10-year avg
-3.04%
Avanos Medical, Inc. (AVNS) ROE vs. Peers
How is AVNS’s ROE compared to its peers?
Avanos Medical, Inc.’s ROE is greater than Artivion, Inc. (-0.29%), greater than Anika Therapeutics, Inc. (-48.10%), greater than Sight Sciences, Inc. (-47.28%), greater than Orthofix Medical Inc. (-21.25%), greater than AxoGen, Inc. (-14.91%), greater than Surmodics, Inc. (-9.56%), greater than Paragon 28, Inc. (-38.77%), greater than Glaukos Corporation (-26.64%), greater than OrthoPediatrics Corp. (-7.64%), less than CONMED Corporation (15.04%), less than LivaNova PLC (1.88%), less than Integer Holdings Corporation (7.30%), greater than Treace Medical Concepts, Inc. (-51.12%), greater than Establishment Labs Holdings Inc. (-184.55%), greater than Nevro Corp. (-24.76%), less than NuVasive, Inc. (4.86%),
| Company | ROE | Market cap |
|---|---|---|
| -0.29% | $1.19B | |
| -48.10% | $237.70M | |
| -47.28% | $178.15M | |
| -21.25% | $662.25M | |
| -14.91% | $756.50M | |
| -9.56% | $564.90M | |
| -38.77% | $844.74M | |
| -26.64% | $8.18B | |
| -7.64% | $547.76M | |
| 15.04% | $2.14B | |
| 1.88% | $2.55B | |
| 7.30% | $4.48B | |
| -51.12% | $433.59M | |
| -184.55% | $1.21B | |
| -24.76% | $141.27M | |
| 4.86% | $2.08B |
Build a custom stock screener for Avanos Medical, Inc. (AVNS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avanos Medical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Avanos Medical, Inc. (AVNS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Avanos Medical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Avanos Medical, Inc.'s ROE?
How is the ROE calculated for Avanos Medical, Inc. (AVNS)?
What is the highest ROE for Avanos Medical, Inc. (AVNS)?
What is the 3-year average ROE for Avanos Medical, Inc. (AVNS)?
What is the 5-year average ROE for Avanos Medical, Inc. (AVNS)?
How does the current ROE for Avanos Medical, Inc. (AVNS) compare to its historical average?